Navigation Links
Access Medical Laboratories, Inc. to Celebrate Grand Opening of New Laboratory Headquarters in Jupiter, Florida
Date:10/25/2011

JUPITER, Fla., Oct. 25, 2011 /PRNewswire/ -- Town officials, physicians from South Florida and around the country as well as people from the community will join Access Medical Laboratories, Inc. on November 8, 2011 to celebrate the completion of the new 25,000 square foot core laboratory and research facility located at 5151 Corporate Way in the Abacoa section of Jupiter. This event will be hosted by Access Medical Laboratories, Inc. President/CEO Mohamed El-Hosseiny, Senior Executive V.P./COO Susan El-Hosseiny and Vice Presidents Sharif, Ryan and Adam El-Hosseiny at 5:00 pm to 7:00 pm, with the ribbon cutting taking place at 5:15 pm. Among the featured guests at the ceremony will be Jupiter mayor Karen J. Golonka, Town Manager Andy Lucasik, Northern Palm Beach Chamber of Commerce staff, Medical Laboratory Director Dr. Alan Sara, MD, Dr. Mark L. Gordon, MD (Los Angeles, CA), who is also in charge of Access's traumatic brain injury research division, Dr. Mitchell Ghen, DO, PHD (Boca Raton, FL), Dr. Naina Sachdev, MD (Portland, OR) and Dr. Edwin Lee, MD, F.A.C.E. (Orlando, FL).

(Photo:  http://photos.prnewswire.com/prnh/20111025/FL92221 )

The state-of-the-art complex consolidates the majority of Access's operations into a single facility, which will foster the company's superior form of diagnostic laboratory services. Access broke ground on the new building in June 2010.

"Our new Headquarters will give us the ability to expand our menu of specialized testing domestically and internationally, bring in more researchers for our Anti-Aging & Esoteric divisions, take our world class customer service to a higher level and further our mission as a laboratory committed to excellence," said Ryan El-Hosseiny. The 3.5 acre site in Abacoa (Jupiter, FL) is where the 25,000 square foot state of the art diagnostic laboratory is located. This will create over 60 jobs in Jupiter's bio-tech community.  

About Access Medical Laboratories, Inc.

Since 2003, Access Medical Labs has been synonymous with innovation. The only one of its kind; Access has created a distinct, superior form of diagnostic laboratory service which has changed the outlook of the laboratory industry throughout the United States. Now in 2011, Access is well known around the world for its research in advanced cardiac, interventional endocrinology/anti-aging and microbiological testing. Access Medical Labs is also the only lab in the nation to develop a complete menu of saliva hormone testing on using the "Gold Standard" method, Liquid Chromatography/Mass Spectrometry (LC/MS/MS). Access Medical Labs will continue to introduce many new cutting edge technologies and a broader spectrum of clinical diagnostic testing.

Access Medical Laboratories™ is a registered trademark of Access Medical Laboratories, Inc.

For More information on Access Medical Laboratories:

www.accessmedlab.com


'/>"/>
SOURCE Access Medical Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
2. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
3. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
4. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
5. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
6. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities
9. Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
10. GeneNews provides Centocor access to its osteoarthritis program
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 23, 2017  Today, the Fisher Center for Alzheimer,s ... an important study that could lead to the development ... Alzheimer,s disease. This groundbreaking research was conducted by the ... Nobel Laureate Dr. Paul Greengard , in the ... Fisher Center scientists have linked a mutation that ...
(Date:1/23/2017)... , Jan. 23, 2017  Spherix Incorporated (Nasdaq: ... to the fostering of technology and monetization of intellectual ... infringement lawsuits. Anthony Hayes , Chief ... we will continue to communicate with shareholders about the ... our due diligence on other patent assets that fit ...
(Date:1/23/2017)... , January 23, 2017 Atlas ... announces completion of its Series D financing, raising $35 million ... new investor, Wondfo Biotech. ... Development of the Atlas Genetics io® system ... Chlamydia trachomatis (CT) test announced in February 2016.  This new ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica from ... and host a hands-on workshop for surgeons to experience the simplicity of the ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
(Date:12/22/2016)... 2016  As part of its longstanding mission to improve ... company, recently released its latest children,s book, titled ... on the topics of inheritance and variation of traits that ... in elementary school classrooms in the US. ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
Breaking Biology News(10 mins):